ISSN: 2278-0238

Revista Internacional de Pesquisa e Desenvolvimento em Farmácia e Ciências da Vida

Acesso livre

Nosso grupo organiza mais de 3.000 Séries de conferências Eventos todos os anos nos EUA, Europa e outros países. Ásia com o apoio de mais 1.000 Sociedades e publica mais de 700 Acesso aberto Periódicos que contém mais de 50.000 personalidades eminentes, cientistas de renome como membros do conselho editorial.

Periódicos de acesso aberto ganhando mais leitores e citações
700 periódicos e 15 milhões de leitores Cada periódico está obtendo mais de 25.000 leitores

Abstrato

SCREENING OF ECLIPTA ALBA EXTRACTS FOR ANTICANCER ACTIVITY

R.B Desireddy, Naga Sowjanya.G, Lavanya Latha Reddy K, Sowjanya. T.

Cancer is the second largest cause of death which killed 7.6 million people worldwide in 2005 (Danaei et al., 2005). The number is believed to become 9 million in 2015 and 11.5 million in 2030 (World Health Organization, 2007). There is an increasing interest to research and develop on new anticancer drugs, from both synthetic and natural sources (Mukherjee et al., 2001). Half of the drugs which have been approved recently are from natural sources. Plants have been extensively used as natural sources to develop anticancer drugs because of their active constituents. Medicinal plants in Asian countries play an important role in cancer treatment and indeed, their chemical constituents and derivatives have been utilized for combating cancers over the last half-century. Presently in the study Eclipta alba ethanolic plant extract has been used for screening the anti-cancer activity in-vitro and the results obtained, gives the evidence that the ethanolic extract inhibit the growth of colon cancer cells at concentrations that showed no apparent toxicity effect against normal cells.